HealthStream, Inc.HSTMNASDAQ
LOADING
|||
R&D Expense Growth Recovery in Progress
Trending higher, below historical average, structural decline.
Left:
||||
Year-over-year research & development expense growth
Latest
7.36%
↓ 41% below average
Average (9y)
12.47%
Historical baseline
Range
High:47.08%
Low:-7.76%
CAGR
-18.6%
Structural decline
| Period | Value |
|---|---|
| 2024 | 7.36% |
| 2023 | 2.85% |
| 2022 | 6.28% |
| 2021 | 28.96% |
| 2020 | 10.98% |
| 2019 | 13.11% |
| 2018 | -7.76% |
| 2017 | -3.45% |
| 2016 | 19.34% |
| 2015 | 47.08% |